Cervix Cancer: Clinical Trials

115 trials for Cervix Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

51 completed, 21 recruiting, 15 unknown, 9 active not recruiting. 39 Not applicable, 24 Phase 1, 22 Phase 2, 7 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable39Completed 19, Active not recruiting 6, Unknown 5, Not yet recruiting 4, Recruiting 4, Terminated 1
Phase 124Completed 10, Recruiting 4, Terminated 4, Unknown 3, Not yet recruiting 2, Withdrawn 1
Phase 222Completed 10, Terminated 4, Not yet recruiting 3, Recruiting 2, Active not recruiting 1, Unknown 1, Withdrawn 1
Phase 37Completed 5, Recruiting 1, Unknown 1
Early Phase 11Completed 1

Follow this condition Literature Review of Cervix Cancer trials Research Report on Cervix Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer
Telaglenastat, Radiation treatment, Cisplatin - Advanced Cervical Carcinoma, Cervical Cancer
Phase 2Not yet recruitingWashington University School of Medicine422026-12-312026-09-03
Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women Living With HIV
Model 1- Screening in Clinic Only, Model 2 - Screening in Clinic and Community - Cervix Cancer, HIV Infections
Not applicableNot yet recruitingUNC Lineberger Comprehensive Cancer Center177342026-09-012026-09-02
Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya
5% 5-fluorouracil Topical Cream, Placebo Cream - HIV Infections, HPV Infection
Phase 2Not yet recruitingUNC Lineberger Comprehensive Cancer Center1402026-09-012026-08-27
Uniting Trusted Community Messengers to Improve Access to Cervical Cancer Screening in Rural North Carolina
Human papilloma virus screening - Cervix Cancer, Screen HPV-positive
Not applicableNot yet recruitingUNC Lineberger Comprehensive Cancer Center1122026-09-012026-08-18
Postoperative Hypofractionated Whole Pelvic Radiotherapy in Cervical and Endometrial Cancer
Hypofractionated Radiotherapy, Conventional Radiotherapy - Endometrial Cancer, Cervix Cancer
Not applicableRecruitingSiriraj Hospital1202026-03-112026-05-19
Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda
Hypofractionated Radiation Therapy, Conventional Fractionated Radiotherapy, Cisplatin - Cervical Cancer, Cervix Cancer
Phase 2RecruitingUganda Cancer Institute2782026-03-112026-03-27
Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV
Model 1- Screening in Clinic Only, Model 2 - Screening in Clinic and Community - Cervix Cancer, HIV Infections
Not applicableRecruitingUNC Lineberger Comprehensive Cancer Center75972026-02-032026-05-28
Hyaluronic Acid-based Gel Spacers in Gynecologic Malignancies
Barrigel gel spacer - Cervix Cancer
Phase 1RecruitingUNC Lineberger Comprehensive Cancer Center142026-02-022026-10-01
Alendronate to Reduce Pelvic Insufficiency Fractures in Cervical Cancer Patients Undergoing Chemoradiation
Alendronate 70mg weekly - Cervix Cancer
Phase 1 / Phase 2Not yet recruitingDr. Itay GoorAryeh652025-12-012025-11-24
AssociatiNG Bevacizumab bEmarituzumab for GynecoLogIcal CAncer
Bemarituzumab, Bevacizumab - Endometrial Carcinoma, Ovarian Cancer
Phase 1 / Phase 2WithdrawnCentre Leon Berard2025-10-152026-04-23
Ultrasound Training Program for Gynecologic Cancer Staging in Residents
Training Group - Medical Education, Ovarian Cancer
Not applicableNot yet recruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS62025-06-162025-06-19
Late Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy Study
Endometrial Cancer, Cervix Cancer
RecruitingTata Memorial Hospital3002025-05-102026-03-02
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
HyperSight cone beam computed tomography (CBCT) scan, ETHOS 2.0 - Uterine Cancer, Rectal Cancer
RecruitingWashington University School of Medicine112025-04-082026-09-02
GYNecologic Cancer-Related COGnitive Impairment
GYNCOG - Ovarian Cancer, Endometrial Cancer
Not applicableCompletedNorthwestern University602025-02-072026-03-23
Evaluation of AK104 (Cadonilimab) Combined with Chemotherapy for Recurrent or Metastatic Small Cell Neuroendocrine Carcinoma of the Cervix
Cervix Cancer, Cadonilimab
Enrolling by invitationDing Ma202025-02-012025-02-06
Evaluation of the Diagnostic and Prognostic Value of Immunohistochemical Markers in Precancerous Lesions of the Cervix
Tissue, diagnostic and prognostic accuracy - Cervix Cancer
Not applicableNot yet recruitingIRCCS Azienda Ospedaliero-Universitaria di Bologna1002025-02-012025-02-28
Minimally Invasive Simple Hysterectomy in Low Risk Cervical Cancer
Minimally invasive simple hysterectomy - Cervical Cancer, Cervix Cancer
Not applicableRecruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS9742024-10-272024-10-29
Prevalence of Abnormal Pap Smear
Screening pap smear test - Cervix Cancer
RecruitingSohag University3002024-10-012024-10-15
Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya
Artesunate pessary, blood draws for pharmacokinetics of the study drug - Cervix Cancer, Cervix Intraepithelial Neoplasia Grade 3
Phase 1CompletedUNC Lineberger Comprehensive Cancer Center122024-05-292025-08-19
A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors
CHT101 - Metastatic Tumor, Advanced Solid Tumor
Phase 1Not yet recruitingZhejiang University182024-04-222024-04-25

Showing 20 of 115. Sign in to see all of them.

Narrower conditions

Uterine Cervical Neoplasms (115)  ·  Ovarian Neoplasms (25)  ·  Endometrial Neoplasms (24)  ·  Breast Neoplasms (15)  ·  Prostatic Neoplasms (13)  ·  Neoplasm Metastasis (10)  ·  Head and Neck Neoplasms (9)  ·  Neoplasms (9)  ·  Papillomavirus Infections (9)  ·  Uterine Cervical Dysplasia (9)  ·  Urinary Bladder Neoplasms (8)  ·  Lung Neoplasms (7)  ·  Esophageal Neoplasms (6)  ·  Uterine Neoplasms (6)  ·  Vulvar Neoplasms (6)

Broader conditions

Female Urogenital Diseases (115)  ·  Female Urogenital Diseases and Pregnancy Complications (115)  ·  Genital Diseases (115)  ·  Genital Diseases, Female (115)  ·  Neoplasms by Site (115)  ·  Urogenital Diseases (115)  ·  Urogenital Neoplasms (115)  ·  Uterine Diseases (115)  ·  Genital Neoplasms, Female (114)  ·  Uterine Cervical Diseases (114)  ·  Uterine Neoplasms (109)  ·  Neoplasms (106)  ·  Adnexal Diseases (26)  ·  Endocrine Gland Neoplasms (26)  ·  Endocrine System Diseases (26)

Interventions

Cisplatin (6)  ·  Radiation Dose Hypofractionation (3)  ·  Radiotherapy (3)  ·  pembrolizumab (3)  ·  tisotumab vedotin (3)  ·  Blood Specimen Collection (2)  ·  Brachytherapy (2)  ·  Magnetic Resonance Spectroscopy (2)  ·  atezolizumab (2)  ·  cemiplimab (2)  ·  3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol (1)  ·  Alendronate (1)  ·  Analgesics, Opioid (1)  ·  Anticoagulants (1)  ·  Art Therapy (1)

Sponsors

UNC Lineberger Comprehensive Cancer Center (7)  ·  Tata Memorial Hospital (5)  ·  Chongqing Precision Biotech Co., Ltd (4)  ·  University Health Network, Toronto (4)  ·  ARCAGY/ GINECO GROUP (3)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (3)  ·  Seagen Inc. (3)  ·  Johns Hopkins Bloomberg School of Public Health (2)  ·  Maastricht Radiation Oncology (2)  ·  National Institute of Cancerología (2)  ·  Northwestern University (2)  ·  Samsung Medical Center (2)  ·  UNICANCER (2)  ·  University Medical Center Groningen (2)  ·  University of Aarhus (2)

Countries

United States (21)  ·  France (13)  ·  Canada (9)  ·  China (9)  ·  India (7)  ·  Brazil (6)  ·  Italy (6)  ·  Denmark (5)  ·  United Kingdom (5)  ·  Belgium (4)  ·  Netherlands (4)  ·  Sweden (4)  ·  Turkey (Türkiye) (4)  ·  Uganda (4)  ·  Germany (3)

Top investigators

Michael Milosevic, MD (3)  ·  Aminur Rahman Shaheen, PhD (2)  ·  Chemtai Mungo, MD MPH (2)  ·  Chemtai Mungo, MD, MPH, FACOG (2)  ·  Emma Barber, MD, MS (2)  ·  Janine de Zeeuw, PhD (2)  ·  Jennifer Smith, PhD (2)  ·  Jennifer Tang, MD (2)  ·  Johann de Bono, Professor (2)  ·  Katie Mollan, PhD (2)  ·  Lameck Chinula, MD (2)  ·  Lisa Spees, PhD (2)  ·  Michael Hudgens, PhD (2)  ·  Robert Pearcey, MD (2)  ·  Vikrant Sahasrabuddhe, MBBS, MPH, DrPH (2)

Results publications

PMID 37496366, PMID 41044356, PMID 11595691, PMID 15863172, PMID 16174242, PMID 16473126, PMID 17655918, PMID 18385498, PMID 18407790, PMID 18801868, PMID 19508716, PMID 19640281, PMID 20556751, PMID 21491379, PMID 21530398, PMID 21907959, PMID 22067707, PMID 22742517, PMID 22914404, PMID 23238407, PMID 23276555, PMID 23380265, PMID 23489374, PMID 23629519, PMID 23777602, PMID 23843155, PMID 24201682, PMID 24264713, PMID 24411029, PMID 24460679, PMID 24886332, PMID 26497721, PMID 26817639, PMID 27296459, PMID 28922235, PMID 29095678, PMID 29787422, PMID 29967015, PMID 30252709, PMID 30380365, PMID 30745090, PMID 30826965, PMID 31298153, PMID 31796521, PMID 33435974, PMID 33957649, PMID 34798899, PMID 35672675, PMID 35840949, PMID 37642347

NIH funding

2019 (2), U24CA275417 (2), UG1CA275403 (2), 2015 (1), 2017 (1), D43TW009759 (1), K12HD103085 (1), K23MD020429 (1), P01CA116602 (1), R01CA181745 (1), R37CA306827 (1), U54CA242639 (1), UG1CA275412 (1), UG1CA284918 (1)